Ayush Chintan Shivir 2026 inaugurated (See 'Corp Brief') A&C - Appeal u/s 19 of Contempt of Courts Act, is not maintainable against order that merely calls for documents & details to ascertain whether there has been violation of status quo order: HC (See 'Legal Desk') Union Govt Secy reviews status of Brackish water Aquaculture cluster notified under PMMSY (See 'Corp Brief') Benami - PBPT Act, 1988 cannot be invoked as substitute to hold parties accountable for alleged violations of IRDAI regulations or any fiscal statutes: SAFEMA (See 'Legal Desk') FIU-Pension Fund Authority sign MoU to combat money laundering and financial crimes (See 'Corp Brief') Union Ministry of Health hosts First BRICS Health Working Group Meeting (See 'Corp Brief') AIIA-iCAINE Marks Excellence at MSME Hackathon 5.0 with Breakthrough Idea Selection (See 'Corp Brief') IBC - Once classified as operational debt, municipal dues cannot claim priority outside statutory waterfall mechanism provided u/s 53 of IBC, 2016, during liquidation: HC (See 'Legal Desk') Nationwide 'Nari Shakti Vandan Run' to be held on 17-18 April across 7 Cities (See 'Corp Brief') NBCFDC Registers Record Performance in FY 2025-26 (See 'Corp Brief') DDWS organises 7th District Collectors' Peyjal Samvad (See 'Corp Brief') IPR - Notices contemplated u/s 25(3) of Trademark Act and RG-3 notices to person who is no longer authorized agent does not constitute compliance with statutory mandate: HC (See 'Legal Desk') Corporate laws (Amendment) Bill 2026 - Proposals affecting auditors (See CORP EINSICHT) NIPER Mohali signs grant agreement with Novartis Healthcare (See 'Corp Brief') NFDC announces Nationwide Release of Malayalam Feature Film Achappa's Album (See 'Corp Brief') IPR - Application of trade mark in India to goods to be exported from India constitutes use within India of trade mark for purpose of establishing infringement and passing off: HC (See 'Legal Desk') MoS calls for Strong Clinical Foundation in Medical Education, notwithstanding AI (See 'Corp Brief') IPR - To determine passing off, focus must be on similarities rather than dissimilarities, and meticulous side-by-side dissection is not necessary and trade dress has to be judged as whole: HC (See 'Legal Desk') India Pharma 2026: Spotlight on Policy, Regulation, AI and CRDMO (See 'Corp Brief') MY Bharat Budget Quest 2026 reaches Grand Culmination Across 17 Zones (See 'Corp Brief') IBC - Multi-state co-operative society can invest in another company, including as resolution applicant under IBC, only if target company is either its subsidiary or engaged in same line of business: SC (See 'Legal Desk') India Pharma highlights Policy Push and Innovation Driving Sectoral Growth (See 'Corp Brief') IBC - Once moratorium is imposed, corporate debtor's pre-CIRP dues cannot be set off against deposit held by creditor: SC (See 'Legal Desk') Ministry of Labour signs MoUs with Porter and Gigin Technologies (See 'Corp Brief') FEMA - SCNs alleging contravention of provisions of FERA merit being quashed, where issued after unjustified delay of 7-10 years, more so where record retention norms generally require preservation for 5-8 years: HC (See 'Legal Desk') Medicine is not just profession, it is a commitment to service of humanity: Murmu (See 'Corp Brief') Misc - Once Freezing Authority identifies properties and forms opinion that they are acquired from illicit source of money derived from drug trafficking, burden of proof shifts entirely onto affected persons to controvert allegations: SAFEMA (See 'Legal Desk') Union Minister jighlights Nari Shakti Vandan Adhiniyam as Transformative Reform (See 'Corp Brief') Bizu Festival Celebrations highlight Cultural Pride and Policy Dialogue on Tribal Development (See 'Corp Brief') India, Kuwait emphasize Dialogue Over Conflict to Secure Energy and Trade Supplies (See 'Corp Brief') Misc - There is no right in borrower to personal hearing by banks before classifying their account as fraud account: SC (See 'Legal Desk') Manohar Lal holds Key Engagements on Infrastructure and Development Cooperation (See 'Corp Brief') CARI Bengaluru gets ISO 15189:2022 Accreditation in Biochemistry (See 'Corp Brief') NI Act - At stage of issuance of process, statutory presumption u/s 139 of NI Act cannot be dislodged in summary manner merely by contending that cheque issued was not for legally enforceable debt: SC (See 'Legal Desk') Barabanki to Bahraich Highway to become Key Cross-Border Trade Lifeline (See 'Corp Brief') Advanced Agriculture fest kicks off in Raisen in MP (See 'Corp Brief') PMLA - Sec 2(1)(u) permits attachment of any property of equivalent value, including properties acquired prior to commission of scheduled offence, which are untraceable: SAFEMA (See 'Legal Desk')

Print

CCI okays internal acquisition by Glaxo Smith Kline

Published: Jan 24, 2022

By TIOLCorplaws News Service

NEW DELHI, JAN 24, 2022: THE Competition Commission of India (CCI) approves acquisition by GlaxoSmithKline Consumer Healthcare Overseas Limited and GlaxoSmithKline Consumer Healthcare UK Trading Limited (Acquirers) of shareholding in GlaxoSmithKline Asia Private Limited (Target) under Section 31(1) of the Competition Act, 2002.

The Proposed Combination involves collective acquisition of 100% shares of the Target by the Acquirers. Further, prior to the proposed combination, GSKAPL will acquire the trademarks pertaining to "Iodex" and "Ostocalcium" brands in India alongwith the legal, economic, commercial and marketing rights of such brands and other associated assets (GSK Consumer Brands) from GlaxoSmithKline Pharmaceuticals Limited.

GlaxoSmithKline Consumer Healthcare Overseas Limited is a wholly-owned subsidiary of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited ("GSK CH HoldCo"). It is a part of the overall GlaxoSmithkline (GSK) group and its principal activity is to act as an investment holding company for GSK CH HoldCo and its subsidiaries.

GlaxoSmithKline Consumer Healthcare UK Trading Limited is a part of the overall GSK group and is a wholly-owned subsidiary of GSK CH HoldCo. It is engaged in the distribution and sale of consumer healthcare products, manufacturing, marketing, providing management services to the consumer healthcare group and providing research and development services to other consumer healthcare companies within the GSK group.

GSKAPL is a consumer healthcare company that is engaged in the marketing and distribution of oral healthcare products under various brand names such as Sensodyne, Parodontax, Polident and over-the-counter medicines products under the brand names such as Crocin, ENO. 

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.